Vancouver, Canada

Marketa Ricicova

This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 5 EPO patents. Top assignee: The University of British Columbia. Active years: 2019-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marketa Ricicova. Retrieved from https://idiyas.com/inventor/marketa-ricicova

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 6.8

ph-index = 1


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Marketa Ricicova: Innovator in Lymphocyte Receptor Research

Introduction

Marketa Ricicova is a prominent inventor based in Vancouver, Canada. She has made significant contributions to the field of immunology through her innovative research and patented technologies. With a total of three patents to her name, Ricicova is recognized for her work in understanding lymphocyte receptor chains and their functionality.

Latest Patents

Ricicova's latest patents include groundbreaking methods for determining lymphocyte receptor chain pairs. These high-throughput sequencing methods are designed to study the diversity and functionality of lymphocyte receptor chains. Specifically, her methods allow for the confident identification of one or more functional lymphocyte receptor chain pairs in a sample. Another notable patent involves microfluidic devices and methods for multicellular assays of secretion. This invention provides methods and devices for identifying cell populations that exert extracellular effects, enhancing the understanding of cellular interactions and responses.

Career Highlights

Marketa Ricicova is affiliated with the University of British Columbia, where she continues her research and development in the field of immunology. Her work has not only advanced scientific knowledge but has also paved the way for potential therapeutic applications.

Collaborations

Ricicova collaborates with esteemed colleagues, including Kevin Albert Heyries and Daniel Jay Da Costa. These partnerships enhance her research capabilities and contribute to the advancement of their shared scientific goals.

Conclusion

Marketa Ricicova is a trailblazer in the field of lymphocyte receptor research, with her innovative patents reflecting her commitment to advancing scientific understanding. Her contributions are poised to have a lasting impact on immunology and related fields.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…